DGX logo

Quest Diagnostics Incorporated (DGX) Free Cash Flow

Annual FCF:

$909.00M+$45.00M(+5.21%)
December 31, 2024

Summary

  • As of today, DGX annual free cash flow is $909.00 million, with the most recent change of +$45.00 million (+5.21%) on December 31, 2024.
  • During the last 3 years, DGX annual free cash flow has fallen by -$921.00 million (-50.33%).
  • DGX annual free cash flow is now -50.33% below its all-time high of $1.83 billion, reached on December 31, 2021.

Performance

DGX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXcash flow metrics

Quarterly FCF:

$419.00M-$17.00M(-3.90%)
September 30, 2025

Summary

  • As of today, DGX quarterly free cash flow is $419.00 million, with the most recent change of -$17.00 million (-3.90%) on September 30, 2025.
  • Over the past year, DGX quarterly free cash flow has increased by +$169.00 million (+67.60%).
  • DGX quarterly free cash flow is now -45.65% below its all-time high of $771.00 million, reached on September 30, 2020.

Performance

DGX Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXcash flow metrics

TTM FCF:

$1.39B+$169.00M(+13.81%)
September 30, 2025

Summary

  • As of today, DGX TTM free cash flow is $1.39 billion, with the most recent change of +$169.00 million (+13.81%) on September 30, 2025.
  • Over the past year, DGX TTM free cash flow has increased by +$370.00 million (+36.17%).
  • DGX TTM free cash flow is now -35.84% below its all-time high of $2.17 billion, reached on June 30, 2021.

Performance

DGX TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

DGX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+5.2%+67.6%+36.2%
3Y3 Years-50.3%+9.1%-4.8%
5Y5 Years+7.8%-45.6%+0.7%

DGX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-50.3%+5.2%-7.9%+1369.7%-4.8%+133.7%
5Y5-Year-50.3%+7.8%-45.6%+1369.7%-35.8%+133.7%
All-TimeAll-Time-50.3%+206.8%-45.6%+1019.0%-35.8%+3058.7%

DGX Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
$419.00M(-3.9%)
$1.39B(+13.8%)
Jun 2025
-
$436.00M(+121.3%)
$1.22B(+15.9%)
Mar 2025
-
$197.00M(-42.2%)
$1.06B(+16.2%)
Dec 2024
$909.00M(+5.2%)
$341.00M(+36.4%)
$909.00M(-11.1%)
Sep 2024
-
$250.00M(-6.7%)
$1.02B(+16.9%)
Jun 2024
-
$268.00M(+436.0%)
$875.00M(-7.6%)
Mar 2024
-
$50.00M(-89.0%)
$947.00M(+9.6%)
Dec 2023
$864.00M(-34.2%)
$455.00M(+346.1%)
$864.00M(+45.0%)
Sep 2023
-
$102.00M(-70.0%)
$596.00M(-32.1%)
Jun 2023
-
$340.00M(+1130.3%)
$878.00M(+1.6%)
Mar 2023
-
-$33.00M(-117.6%)
$864.00M(-34.2%)
Dec 2022
$1.31B(-28.2%)
$187.00M(-51.3%)
$1.31B(-10.2%)
Sep 2022
-
$384.00M(+17.8%)
$1.46B(-5.7%)
Jun 2022
-
$326.00M(-21.8%)
$1.55B(-3.1%)
Mar 2022
-
$417.00M(+23.7%)
$1.60B(-12.5%)
Dec 2021
$1.83B(+15.3%)
$337.00M(-28.6%)
$1.83B(-2.2%)
Sep 2021
-
$472.00M(+25.5%)
$1.87B(-13.8%)
Jun 2021
-
$376.00M(-41.7%)
$2.17B(+5.0%)
Mar 2021
-
$645.00M(+70.2%)
$2.07B(+30.3%)
Dec 2020
$1.59B(+88.3%)
$379.00M(-50.8%)
$1.59B(+14.7%)
Sep 2020
-
$771.00M(+182.4%)
$1.38B(+69.6%)
Jun 2020
-
$273.00M(+66.5%)
$816.00M(+4.7%)
Mar 2020
-
$164.00M(-6.8%)
$779.00M(-7.6%)
Dec 2019
$843.00M(+3.2%)
$176.00M(-13.3%)
$843.00M(+3.9%)
Sep 2019
-
$203.00M(-14.0%)
$811.00M(-12.7%)
Jun 2019
-
$236.00M(+3.5%)
$929.00M(-1.0%)
Mar 2019
-
$228.00M(+58.3%)
$938.00M(+14.8%)
Dec 2018
$817.00M(-11.5%)
$144.00M(-55.1%)
$817.00M(-10.6%)
Sep 2018
-
$321.00M(+31.0%)
$914.00M(+2.5%)
Jun 2018
-
$245.00M(+129.0%)
$892.00M(+1.8%)
Mar 2018
-
$107.00M(-55.6%)
$876.00M(-5.1%)
Dec 2017
$923.00M(+12.2%)
$241.00M(-19.4%)
$923.00M(+7.6%)
Sep 2017
-
$299.00M(+30.6%)
$858.00M(+7.4%)
Jun 2017
-
$229.00M(+48.7%)
$799.00M(-3.0%)
Mar 2017
-
$154.00M(-12.5%)
$824.00M(+6.2%)
Dec 2016
$823.00M(+47.5%)
$176.00M(-26.7%)
$776.00M(-0.1%)
Sep 2016
-
$240.00M(-5.5%)
$777.00M(+11.5%)
Jun 2016
-
$254.00M(+139.6%)
$697.00M(+6.1%)
Mar 2016
-
$106.00M(-40.1%)
$657.00M(+20.1%)
Dec 2015
$558.00M(-12.3%)
$177.00M(+10.6%)
$547.00M(-6.3%)
Sep 2015
-
$160.00M(-25.2%)
$584.00M(-1.5%)
Jun 2015
-
$214.00M(+5450.0%)
$593.00M(-2.8%)
Mar 2015
-
-$4.00M(-101.9%)
$610.00M(-3.2%)
Dec 2014
$636.00M(+51.1%)
$214.00M(+26.6%)
$630.00M(+14.4%)
Sep 2014
-
$169.00M(-26.8%)
$550.82M(+6.5%)
Jun 2014
-
$231.00M(+1343.8%)
$517.39M(+17.9%)
Mar 2014
-
$16.00M(-88.1%)
$438.85M(+4.2%)
Dec 2013
$421.00M(-58.1%)
$134.82M(-0.6%)
$421.00M(-30.6%)
Sep 2013
-
$135.57M(-11.1%)
$606.68M(-26.1%)
Jun 2013
-
$152.46M(+8323.3%)
$820.81M(-5.8%)
Mar 2013
-
-$1.85M(-100.6%)
$871.81M(-13.2%)
Dec 2012
$1.00B(+36.9%)
$320.50M(-8.4%)
$1.00B(+2.7%)
Sep 2012
-
$349.71M(+71.9%)
$978.51M(+5.5%)
Jun 2012
-
$203.46M(+55.0%)
$927.18M(+24.7%)
Mar 2012
-
$131.27M(-55.4%)
$743.60M(+1.3%)
Dec 2011
$734.00M
$294.07M(-1.4%)
$733.92M(+3.3%)
Sep 2011
-
$298.39M(+1401.7%)
$710.33M(+2.3%)
Jun 2011
-
$19.87M(-83.7%)
$694.57M(-16.8%)
DateAnnualQuarterlyTTM
Mar 2011
-
$121.59M(-55.0%)
$834.78M(-8.5%)
Dec 2010
$912.65M(+9.9%)
$270.48M(-4.3%)
$912.65M(-4.2%)
Sep 2010
-
$282.63M(+76.6%)
$952.59M(-5.0%)
Jun 2010
-
$160.08M(-19.7%)
$1.00B(+25.8%)
Mar 2010
-
$199.45M(-35.7%)
$796.79M(-4.1%)
Dec 2009
$830.49M(-2.3%)
$310.42M(-6.6%)
$830.49M(+2.5%)
Sep 2009
-
$332.51M(+829.3%)
$810.47M(+6.4%)
Jun 2009
-
-$45.59M(-119.6%)
$761.54M(-21.7%)
Mar 2009
-
$233.15M(-19.7%)
$972.54M(+14.4%)
Dec 2008
$850.37M(+20.1%)
$290.40M(+2.4%)
$850.37M(+1.3%)
Sep 2008
-
$283.58M(+71.4%)
$839.17M(+5.8%)
Jun 2008
-
$165.41M(+49.0%)
$793.20M(+12.1%)
Mar 2008
-
$110.98M(-60.2%)
$707.38M(-0.1%)
Dec 2007
$707.82M(-6.7%)
$279.20M(+17.5%)
$707.82M(+4.9%)
Sep 2007
-
$237.61M(+198.6%)
$674.81M(+7.7%)
Jun 2007
-
$79.59M(-28.6%)
$626.52M(-6.7%)
Mar 2007
-
$111.43M(-54.7%)
$671.43M(-11.5%)
Dec 2006
$758.47M(+20.9%)
$246.19M(+30.0%)
$758.47M(-1.5%)
Sep 2006
-
$189.32M(+52.1%)
$769.76M(+9.4%)
Jun 2006
-
$124.49M(-37.3%)
$703.64M(-5.6%)
Mar 2006
-
$198.47M(-22.9%)
$745.14M(+18.8%)
Dec 2005
$627.31M(+0.7%)
$257.47M(+109.0%)
$627.31M(+6.1%)
Sep 2005
-
$123.20M(-25.8%)
$591.44M(-7.9%)
Jun 2005
-
$165.99M(+105.8%)
$642.02M(+0.7%)
Mar 2005
-
$80.65M(-63.6%)
$637.75M(+2.4%)
Dec 2004
$622.65M(+27.6%)
$221.59M(+27.5%)
$622.65M(+2.0%)
Sep 2004
-
$173.78M(+7.5%)
$610.40M(+8.3%)
Jun 2004
-
$161.72M(+146.7%)
$563.56M(+5.8%)
Mar 2004
-
$65.55M(-68.7%)
$532.89M(+9.2%)
Dec 2003
$488.16M(+10.6%)
$209.34M(+64.9%)
$488.16M(-0.1%)
Sep 2003
-
$126.95M(-3.1%)
$488.47M(+6.5%)
Jun 2003
-
$131.05M(+529.5%)
$458.49M(+1.8%)
Mar 2003
-
$20.82M(-90.1%)
$450.41M(+2.1%)
Dec 2002
$441.18M(+39.3%)
$209.65M(+116.2%)
$441.18M(+23.5%)
Sep 2002
-
$96.97M(-21.1%)
$357.24M(-5.5%)
Jun 2002
-
$122.97M(+961.2%)
$378.17M(+14.2%)
Mar 2002
-
$11.59M(-90.8%)
$331.29M(+4.6%)
Dec 2001
$316.82M(+25.2%)
$125.72M(+6.6%)
$316.82M(+19.3%)
Sep 2001
-
$117.89M(+54.9%)
$265.61M(+17.0%)
Jun 2001
-
$76.09M(+2738.2%)
$226.93M(-3.3%)
Mar 2001
-
-$2.88M(-103.9%)
$234.58M(-7.3%)
Dec 2000
$253.00M(+129.7%)
$74.51M(-5.9%)
$253.00M(+18.8%)
Sep 2000
-
$79.22M(-5.4%)
$213.01M(-13.4%)
Jun 2000
-
$83.73M(+438.7%)
$246.11M(+38.1%)
Mar 2000
-
$15.54M(-55.0%)
$178.16M(+2.7%)
Dec 1999
-$851.50M(-943.9%)
$34.52M(-69.3%)
$173.51M(+5.6%)
Sep 1999
-
$112.32M(+612.0%)
$164.27M(+53.9%)
Jun 1999
-
$15.78M(+44.8%)
$106.75M(+13.4%)
Mar 1999
-
$10.89M(-56.9%)
$94.10M(-7.6%)
Dec 1998
$100.90M(-22.1%)
$25.28M(-53.9%)
$101.81M(+13.5%)
Sep 1998
-
$54.80M(+1648.4%)
$89.72M(+7.2%)
Jun 1998
-
$3.13M(-83.1%)
$83.73M(-19.5%)
Mar 1998
-
$18.59M(+40.9%)
$104.00M(-19.7%)
Dec 1997
$129.50M(+181.5%)
$13.20M(-73.0%)
$129.50M(+11.3%)
Sep 1997
-
$48.80M(+108.5%)
$116.30M(+72.3%)
Jun 1997
-
$23.40M(-46.9%)
$67.50M(+53.1%)
Mar 1997
-
$44.10M
$44.10M
Dec 1996
-$158.88M
-
-

FAQ

  • What is Quest Diagnostics Incorporated annual free cash flow?
  • What is the all-time high annual free cash flow for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated annual free cash flow year-on-year change?
  • What is Quest Diagnostics Incorporated quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated quarterly free cash flow year-on-year change?
  • What is Quest Diagnostics Incorporated TTM free cash flow?
  • What is the all-time high TTM free cash flow for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated TTM free cash flow year-on-year change?

What is Quest Diagnostics Incorporated annual free cash flow?

The current annual free cash flow of DGX is $909.00M

What is the all-time high annual free cash flow for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high annual free cash flow is $1.83B

What is Quest Diagnostics Incorporated annual free cash flow year-on-year change?

Over the past year, DGX annual free cash flow has changed by +$45.00M (+5.21%)

What is Quest Diagnostics Incorporated quarterly free cash flow?

The current quarterly free cash flow of DGX is $419.00M

What is the all-time high quarterly free cash flow for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high quarterly free cash flow is $771.00M

What is Quest Diagnostics Incorporated quarterly free cash flow year-on-year change?

Over the past year, DGX quarterly free cash flow has changed by +$169.00M (+67.60%)

What is Quest Diagnostics Incorporated TTM free cash flow?

The current TTM free cash flow of DGX is $1.39B

What is the all-time high TTM free cash flow for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high TTM free cash flow is $2.17B

What is Quest Diagnostics Incorporated TTM free cash flow year-on-year change?

Over the past year, DGX TTM free cash flow has changed by +$370.00M (+36.17%)
On this page